Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy.

Ajibola, S.O.; Adeyemo, T.A.; Afolabi, B.B.; Akanmu, A.S.

Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy.

Files

AFOLABI Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy..pdf(986.9 KB)

Date

2016-08

Authors

Ajibola, S.O.

Adeyemo, T.A.

Afolabi, B.B.

Akanmu, A.S.

Publisher

Niger Med J.

Abstract

Preeclampsia (PE) is the second most common cause of maternal death after obstetric hemorrhage in Africa, a resource-limited region. This study was designed to examine the potential usefulness of a single screening plasma plasminogen activator inhibitor-1 (PAI-1) and fibronectin (FN) level for the prediction of PE in pregnant women.

Keywords

Fibronectin , Plasminogen , Activator inhibitor-1 , Preeclampsia

Citation

Ajibola SO, Adeyemo TA, Afolabi BB, Akanmu AS. Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy. Niger Med J. 2016 Jul-Aug;57(4):213-6. doi: 10.4103/0300-1652.188337. PubMed PMID: 27630384; PubMed Central PMCID: PMC4995812.

URI

https://ir.unilag.edu.ng/handle/123456789/8824

Collections

Obstetrics and Gynaecology- Scholarly Publications

Full item page